FinancialNewsMedia.com News Commentary
Palm Beach, FL, July 18, 2022 /PRNewswire/ -- Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by poor air quality have asthma, chronic obstructive pulmonary disease (COPD), and heart disease. Some of the companies tackling these soaring health problems include GlaxoSmithKline (NYSE: GSK), AstraZeneca (NASDAQ: AZN), Regeneron Pharmaceuticals Inc (NASDAQ: REGN), and Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL).
Read more at prnewswire.com